Coinfection of pneumocystis jiroveci pneumonia and pulmonary aspergillosis in a non-HIV-infected patient

J Microbiol Immunol Infect. 2018 Dec;51(6):860-861. doi: 10.1016/j.jmii.2018.11.001. Epub 2018 Nov 12.

Authors

Po-Hsin Lee¹, Pin-Kuei Fu²

Affiliations

¹ Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
² Department of Critical Care Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; College of Human Science and Social Innovation, Hungkuang University, Taichung, 43302, Taiwan; School of Chinese Medicine, China Medical University, Taichung, 40447, Taiwan. Electronic address: yetquen@gmail.com.

PMID: 30473143
DOI: 10.1016/j.jmii.2018.11.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Antifungal Agents / therapeutic use
Antigens, Fungal / blood
Bronchoalveolar Lavage Fluid / microbiology
Coinfection / diagnosis*
Coinfection / drug therapy
Coinfection / immunology
Coinfection / pathology
Female
Humans
Immunocompromised Host
Kidney Transplantation / adverse effects
Lung / diagnostic imaging
Lung / microbiology
Pneumonia, Pneumocystis / complications*
Pneumonia, Pneumocystis / diagnosis*
Pneumonia, Pneumocystis / drug therapy
Pneumonia, Pneumocystis / pathology
Pulmonary Aspergillosis / complications*
Pulmonary Aspergillosis / diagnosis*
Pulmonary Aspergillosis / drug therapy
Pulmonary Aspergillosis / pathology
Treatment Outcome

Substances

Anti-Bacterial Agents
Antifungal Agents
Antigens, Fungal